Your institution may have access to this item. Find your institution then sign in to continue.
Title
Phase II study of single-agent bosutinib, a Src/Abl tyrosine kinase inhibitor, in patients with locally advanced or metastatic breast cancer pretreated with chemotherapy.
Authors
Campone, M.; Bondarenko, I.; Brincat, S.; Hotko, Y.; Munster, P. N.; Chmielowska, E.; Fumoleau, P.; Ward, R.; Bardy-Bouxin, N.; Leip, E.; Turnbull, K.; Zacharchuk, C.; Epstein, R. J.